News Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 3, 2023Tactoset cleared by the FDA to be combined with autologous bone marrow aspirate, a core element for regenerative healing
BEDFORD, Mass., April 3, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received an...
-
Mar 27, 2023
BEDFORD, Mass., March 27, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global joint preservation company in early intervention orthopedics, today...
-
Mar 15, 2023
BEDFORD, Mass. — March 15, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Mar 8, 2023Recently Commenced Full Market Release of X-Twist™ Fixation System, a Cornerstone Product in Anika’s Sports Medicine Portfolio
BEDFORD, Mass., March 8, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced it is highlighting recently-launched products in high growth segments...
-
Mar 6, 2023Delivered Fourth Quarter Revenue Growth of 11% and Full Year 2022 Revenue Growth of 6%
BEDFORD, Mass., March 6, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its fourth...
-
Feb 28, 2023
BEDFORD, Mass. — February 28, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Feb 21, 2023
BEDFORD, Mass., February 21, 2023 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
-
Feb 21, 2023
BEDFORD, Mass., February 21, 2023 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today issued the following statement in...
-
Feb 13, 2023RevoMotion significantly expands Anika’s shoulder arthroplasty portfolio and provides a new solution in the over $800 million U.S. reverse shoulder market
BEDFORD, Mass., February 13, 2023-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has commenced...
-
Nov 8, 2022Third Quarter Revenue Growth of 2%
BEDFORD, Mass., November 8, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its third...
-
Nov 1, 2022Study Demonstrated Superiority of Cingal, a Single-Injection Hyaluronic Acid-Based Viscosupplement Combined with Fast-Acting Steroid, Over Steroid Alone, for Osteoarthritis Pain Relief at 26 Weeks
BEDFORD, Mass., November 1, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that Cingal® met its...
-
Oct 25, 2022
BEDFORD, Mass., October 25, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...
-
Sep 12, 2022X-Twist expands Anika’s sports medicine portfolio with a cornerstone suture anchor system ideal for key repairs in the shoulder, foot and ankle, and other extremities
BEDFORD, Mass., September 12, 2022-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the limited market...
-
Aug 3, 2022Second quarter revenue growth up 4%
X-Twist™ 510(k) clearance received; Limited market release on schedule for 2H 2022BEDFORD, Mass., August 3, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its second...
-
Jul 27, 2022
BEDFORD, Mass., July 27, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received the...
-
Jul 12, 2022
BEDFORD, Mass., July 12, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its...
-
Jun 10, 2022
BEDFORD, Mass. — June 10, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
May 20, 2022X-Twist provides a simple, versatile knotless suture anchor system ideal for key repairs in the shoulder, foot and ankle, and other extremities
BEDFORD, Mass., May 19, 2022-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received 510(k)...
-
May 13, 2022
BEDFORD, Mass., May 13, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 2, 2022, Anika granted...
-
May 9, 2022
BEDFORD, Mass. — May 9, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate...
-
May 5, 2022First quarter revenue growth of 7% year-over-year driven by favorable order timing in OA Pain Management
BEDFORD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results...
-
Apr 15, 2022
BEDFORD, Mass., April 15, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on April 1, 2022, Anika...
-
Apr 7, 2022
BEDFORD, Mass., April 7, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its...
-
Apr 4, 2022
BEDFORD, Mass. — April 4, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
-
Mar 23, 2022Anika is an innovative joint preservation company focused on the early intervention orthopedic continuum of care including OA pain management, regenerative solutions, sports medicine, and bone preserving joint technologies.
BEDFORD, Mass., March 23, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced it will showcase its comprehensive joint preservation and...